Category: Company News

The former Ballard Power Systems executive will oversee manufacturing improvements at Plug Power’s Rochester Gigafactory as the company advances its global electrolyzer project portfolio. Key Investor Takeaways Why PLUG Stock Is in Focus Plug Power (NASDAQ:PLUG) has appointed Dr. Lee Sweetland to oversee the industrialization of its proton exchange membrane (PEM) stack technology, a key…

The $225,000 preferred-stock transaction establishes an operating platform in the Caribbean, with up to $3 million in additional consideration tied to future revenue milestones. Key Investor Takeaways Why AIBT Stock Is in Focus AIBotics (USOTC:AIBT) has completed the acquisition of operating assets associated with Jamaica-based NovaCore Labs, establishing a platform for expanding its artificial intelligence,…

Kraig Labs will address the commercial potential of genetically engineered spider silk at a November industry conference in India, providing an opportunity to engage with international silk producers and potential industry partners. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Biocraft Laboratories (USOTC:KBLB) has announced that Chief Operating Officer Jon Rice will present…

NXGen Brands reports zero outstanding debt and a nearly 30% reduction in its common share count as new management prepares for a subsidiary acquisition and further corporate restructuring. Key Investor Takeaways Why NXGB Stock Is in Focus NXGen Brands (USOTC:NXGB) has announced several completed corporate restructuring measures under its ongoing Operation “Cleanup” initiative, including a…

SPYR’s first strategic transaction following its court-supervised restoration would bring a revenue-generating AI accounting business into the company, with audited financial statements and an SEC registration planned. Key Investor Takeaways Why SPYR Stock Is in Focus SPYR, Inc. (USOTC:SPYR) has entered into a binding stock purchase agreement with Certus Food LLC, operating as Ledjr AI,…

Anavex Life Sciences gains regulatory clearance to begin U.S. clinical testing of blarcamesine for Fragile X syndrome, expanding its active development programs across three neurological indications. Key Investor Takeaways Why AVXL Stock Is in Focus Anavex Life Sciences (NASDAQ:AVXL) has secured FDA IND clearance for its investigational drug ANAVEX2-73, also known as blarcamesine, in Fragile…

Fractyl Health reports statistically significant reductions in weight regain following GLP-1 discontinuation, advancing its Revita treatment toward a potential FDA submission in late 2026. Key Investor Takeaways Why GUTS Stock Is in Focus Fractyl Health (NASDAQ:GUTS) has reported positive six-month results from its ongoing REMAIN-1 pivotal trial, meeting the first of two co-primary endpoints for…

SANGRIX advances its AI infrastructure deployment plans with a revised delivery timetable for its $11 million server project, shifting attention toward commissioning and commercial operations. Key Investor Takeaways Why SGRX Stock Is in Focus SANGRIX (NASDAQ:SGRX), formerly Bit Origin Ltd, has established a November 2026 delivery schedule for its first NVIDIA Blackwell B300 AI infrastructure…

American Fusion (USOTC:AMFN) has upgraded key equipment for its Texatron Fusion Engine testing programme while pursuing potential commercial deployments, scientific review and financing discussions. The developments indicate progress across several workstreams, although technical validation and binding customer agreements remain outstanding. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion has provided an operational…

NioCorp Developments (NASDAQ:NB) has signed a binding 15-year agreement with Traxys North America, extending commercial arrangements across its planned Elk Creek critical minerals production and potentially strengthening its position in financing discussions with the U.S. Export-Import Bank. Key Investor Takeaways Why NB Stock Is in Focus NioCorp Developments has reached a definitive commercial agreement with…